EP3205334
Aðferð og samsetning til að meðhöndla augnháþrýsting og gláku
Status:
EP Einkaleyfi ógilt eftir andmæliEP appl. date:
28.5.2009EP published:
29.4.2020EP application number:
17000440.2
EP translation filed:
8.7.2020Grant published:
15.8.2020EPO information:
European Patent Register
Max expiry date:
27.5.2029Expiry date:
27.5.2025
Title:
METHOD AND COMPOSITION FOR TREATING OCULAR HYPERTENSION AND GLAUCOMA
Timeline
Today
28.5.2009EP application
29.4.2020EP Publication
8.7.2020Translation submitted
15.8.2020Registration published
27.5.2025Expires
Owner
Name:
Santen Pharmaceutical Co., Ltd.Address:
9-19, Shimoshinjo 3-chome, Higashiyodogawa-ku Osaka-shi Osaka 533-8651, JP
Name:
AGC Inc.Address:
5-1, Marunouchi 1-chome, Chiyoda-ku, Tokyo 100-8405, JP
Inventor
Name:
REUNAMAKI, TimoAddress:
33820 Tampere, FI
Name:
PELLINEN, PerttiAddress:
33880 Lempaala, FI
Name:
OKSALA, OlliAddress:
33240 Tampere, FI
Name:
LEHMUSSAARI, KariAddress:
33580 Tampere, FI
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
08397513Date:
30.5.2008Country:
EP
Classification
Categories:
A61K 9/08, A61K 47/10, A61K 47/26, A61K 47/18, A61K 31/5575
Annual fees
Number
Paid
Expires
Payer
Number: 12
Paid: 8.7.2020
Expires: 27.5.2021
Payer: Patice ehf.
Number: 13
Paid: 8.4.2021
Expires: 27.5.2022
Payer: Árnason Faktor ehf.
Number: 14
Paid: 5.4.2022
Expires: 27.5.2023
Payer: Árnason Faktor ehf.
Number: 15
Paid: 12.4.2023
Expires: 27.5.2024
Payer: Árnason Faktor ehf.
Number: 16
Paid: 9.4.2024
Expires: 27.5.2025
Payer: Árnason Faktor ehf.